PhRMA Initiates Advertising Campaign Against 340B Drug Discount Program

The Pharmaceutical Research and Manufacturers of America (PhRMA) has commenced a new advertising campaign with a seven-figure budget, targeting the federal 340B drug discount program.

This initiative seeks to raise awareness and potentially influence public perception regarding the program, which provides discounts on medications for certain healthcare providers.

Additionally, the campaign includes mentions of Novo's obesity pill sales, suggesting a broader focus on pharmaceutical pricing and access issues.